JP2024540479A5 - - Google Patents
Info
- Publication number
- JP2024540479A5 JP2024540479A5 JP2024529329A JP2024529329A JP2024540479A5 JP 2024540479 A5 JP2024540479 A5 JP 2024540479A5 JP 2024529329 A JP2024529329 A JP 2024529329A JP 2024529329 A JP2024529329 A JP 2024529329A JP 2024540479 A5 JP2024540479 A5 JP 2024540479A5
- Authority
- JP
- Japan
- Prior art keywords
- manufacturing
- protease antigen
- igm protease
- pressure
- coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21208911.4 | 2021-11-18 | ||
| EP21208911 | 2021-11-18 | ||
| PCT/EP2022/082177 WO2023088988A1 (en) | 2021-11-18 | 2022-11-17 | A method to produce a vaccine against streptococcus suis and the said vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540479A JP2024540479A (ja) | 2024-10-31 |
| JP2024540479A5 true JP2024540479A5 (cg-RX-API-DMAC7.html) | 2025-10-20 |
Family
ID=78695535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529329A Pending JP2024540479A (ja) | 2021-11-18 | 2022-11-17 | ストレプトコッカス・スイスに対するワクチンの製造方法およびそのワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240424077A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4433079A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024540479A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118265540A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023088988A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026114933A1 (en) | 2024-11-27 | 2026-06-04 | Intervet International B.V. | Stable vaccine against streptococcus suis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015181856A1 (ja) | 2014-05-30 | 2015-12-03 | 株式会社アーバンマテリアルズ | 弦楽器用エンドピン |
| EP2949340A1 (en) | 2014-05-30 | 2015-12-02 | IDT Biologika GmbH | Vaccine composition against Streptococcus suis infection |
| US11155585B2 (en) | 2015-07-09 | 2021-10-26 | Intervacc Ab | Vaccine against S. suis infection |
| AU2017214441B2 (en) * | 2016-02-04 | 2021-08-19 | Genovis Ab | New Streptococcal proteases |
-
2022
- 2022-11-17 EP EP22818340.6A patent/EP4433079A1/en active Pending
- 2022-11-17 US US18/708,248 patent/US20240424077A1/en active Pending
- 2022-11-17 JP JP2024529329A patent/JP2024540479A/ja active Pending
- 2022-11-17 WO PCT/EP2022/082177 patent/WO2023088988A1/en not_active Ceased
- 2022-11-17 CN CN202280076533.0A patent/CN118265540A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cheng et al. | Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme | |
| JP2009516529A5 (cg-RX-API-DMAC7.html) | ||
| JP2015512449A5 (cg-RX-API-DMAC7.html) | ||
| JP5041445B2 (ja) | マイコプラズマprrsvに対するワクチン | |
| Wang et al. | Phosphoglycerate kinase enhanced immunity of the whole cell of Streptococcus agalactiae in tilapia, Oreochromis niloticus | |
| DE202015009979U1 (de) | Impfstoffzusammensetzung gegen eine Streptococcus suis Infektion | |
| JP2010516763A5 (cg-RX-API-DMAC7.html) | ||
| Carvalho et al. | Development of production and purification processes of recombinant fragment of pneumococcal surface protein A in Escherichia coli using different carbon sources and chromatography sequences | |
| LiHua et al. | Evaluation of an outer membrane protein as a vaccine against Edwardsiella anguillarum in Japanese eels (Anguilla japonica) | |
| JP2011506433A5 (cg-RX-API-DMAC7.html) | ||
| JP2023154063A (ja) | 肺炎球菌表面タンパク質A(PspA)の発現 | |
| JP2022009021A5 (cg-RX-API-DMAC7.html) | ||
| JP2019505567A5 (cg-RX-API-DMAC7.html) | ||
| Oishi et al. | Global control of pneumococcal infections by pneumococcal vaccines | |
| Zhao et al. | Analysis of efficacy obtained with a trivalent inactivated Haemophilus parasuis serovars 4, 5, and 12 vaccine and commercial vaccines against Glässer’s disease in piglets | |
| CN103432579B (zh) | 一种羔羊痢疾b型产气荚膜梭菌类毒素疫苗的制备方法 | |
| Yu et al. | Identification of antigenic Edwardsiella tarda surface proteins and their role in pathogenesis | |
| CN101157907B (zh) | 一种表达猪源支气管败血波氏杆菌fhaB和prn基因片段的重组猪霍乱沙门氏菌株、疫苗及应用 | |
| US10960066B2 (en) | Streptococcus pneumoniae vaccine | |
| CN101940786B (zh) | 副猪嗜血杆菌免疫原性蛋白基因PilA的应用 | |
| CN108524926A (zh) | 一种多价肺炎球菌结合疫苗的制剂组合及其应用 | |
| Kuzyk et al. | OspA, a lipoprotein antigen of the obligate intracellular bacterial pathogen Piscirickettsia salmonis | |
| JP2004508339A5 (cg-RX-API-DMAC7.html) | ||
| EP0914152A1 (fr) | Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant | |
| EP1657248A2 (en) | Vaccine for preventing and treating porcine progressive atrophic rhinitis |